ATX — Amplia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$41.05m
- AU$13.53m
Annual cashflow statement for Amplia Therapeutics, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -0.954 | -1.07 | -1.35 | -0.968 | -0.93 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.4 | -5.29 | -5.13 | -6.89 | -8.73 |
| Capital Expenditures | -0.014 | -0.018 | -0.002 | -0.002 | -0.033 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.012 | -0.041 | 0 | — | -0.063 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.027 | -0.058 | -0.002 | -0.002 | -0.096 |
| Financing Cash Flow Items | -1.18 | -0.041 | -0.693 | -2.88 | -1.88 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.2 | -0.084 | -0.773 | 14.3 | 25.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.8 | -5.35 | -5.87 | 7.48 | 17 |